FRANKLIN, Mass., January 31, 2023 — Cold Chain Technologies, LLC (“CCT” or “Company”), provider of thermal packaging assurance solutions for temperature-sensitive products for the life sciences industry, has announced the launch of CCT TheraShieldTM, a dedicated portfolio of products and customized services to support the cell and gene therapy industry.
CCT TheraShield is a broad range of advanced, reusable thermal packaging solutions and is directly linked to the CCT Smart SolutionsTM portal to support the needs of the cell and gene therapy industry. The recently launched CCT Smart Solutions portal offers various digital solutions to help customers plan, create, track, and optimize their shipments and is the backbone of this offering. This portfolio will be available in various temperature profiles, sizes, and has been tested against the most robust industry standards. Additionally, CCT TheraShield leverages the company’s substantial experience in managing ultra-low temperature shipments with reusable services, which were showcased throughout the distribution of the mRNA Covid-19 vaccine. Read More >>
This post is related to:
Cold Chain Management
